Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms insider activity: Chief Financial Officer Thilo Wrede exercised employee stock options and sold common shares on 08/14/2025. The CFO exercised options with a $13.91 exercise price to acquire 7,189 shares, and reported ownership of 14,378 derivative shares following the transactions. On the same date, the Reporting Person sold 600 shares at a weighted average price of $47.06 and 2,793 shares at a weighted average price of $47.70 under a Rule 10b5-1 trading plan adopted May 15, 2025. Beneficial ownership reported after the transactions ranged from 62,176 to 58,783 common shares in the table entries.
Notice of proposed sale of 9,999 common shares by a person associated with Vital Farms, Inc. (VITL). The filing names Morgan Stanley Smith Barney LLC as the broker and lists an aggregate market value of $476,947.30 for the shares, against 44,685,980 shares outstanding. The planned approximate sale date is 08/15/2025. The shares were acquired through restricted stock vesting on 03/10/2024 (9,609 shares) and 04/26/2024 (390 shares). The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.
The filing notifies a proposed sale of 12,005 shares of Vital Farms, Inc. common stock, with an aggregate market value of $573,238.75, to be sold on or about 08/15/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The shares were acquired as Restricted Stock Units on 03/22/2022 from the issuer. The filing reports 44,685,980 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. No additional remarks, trading plan date, or signatures are provided in the disclosed content.
Vital Farms, Inc. (VITL) Form 4: Director Karl Khoury reported the sale of 20,000 shares of Vital Farms common stock on 08/13/2025 at a weighted average price of $47.63 per share, with prices in the range $47.60 to $47.64. After the sale, Mr. Khoury beneficially owned 114,789 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025 and indicates the filing was submitted by a single reporting person. The filing discloses the weighted-average pricing and offers to provide details of the number of shares sold at each price within the stated range.
Russell Diez-Canseco, President, CEO and Director of Vital Farms, Inc. (VITL), reported an open-market sale of 16,700 shares on 08/12/2025 under a Rule 10b5-1 trading plan adopted May 12, 2025. The filing shows a weighted average sale price of $46.11, with individual trade prices ranging from $45.39 to $46.31. After the disposition, the reporting person beneficially owns 702,476 shares directly, which includes 277 shares acquired on May 15, 2025 under the companys Employee Stock Purchase Plan. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Stephanie Coon, SVP Strategy at Vital Farms, Inc. (VITL), reported an insider sale. On 08/12/2025 she disposed of 10,005 shares of Vital Farms common stock in transactions executed at a weighted average price of $46.15 per share. After the sale she beneficially owned 45,779 shares. The filing notes 359 shares included in the post-transaction total were purchased on May 15, 2025 under the company Employee Stock Purchase Plan in an exempt transaction. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Form 144 notice for Vital Farms, Inc. (VITL): The filer proposes to sell 3,393 shares of Common stock with an aggregate market value of $161,981.82. The shares are scheduled for sale on or about 08/14/2025 on NASDAQ. The securities were acquired as Restricted Stock Units from the issuer on 03/17/2024 and the acquisition/vesting date is recorded as 03/17/2024. The filing also discloses three prior 10b5-1 sales by the same account: 1,200 shares sold on 06/12/2025 for $38,316.00, 1,200 shares sold on 07/11/2025 for $46,764.00, and 1,200 shares sold on 08/11/2025 for $54,672.00. Certain filer identification fields (CIK/Name) and contact details are not provided in the visible content.
Vital Farms, Inc. is the subject of a Form 144 reporting a proposed sale of 6,086 common shares with an aggregate market value of $290,376.64, slated for sale on 08/14/2025 on Nasdaq. The filing shows these securities were acquired on 08/11/2025 as a stock bonus from Vital Farms Inc, where the holder received 18,475 shares and now proposes to sell a portion. The company has 44,685,980 shares outstanding, so the proposed sale represents approximately 0.014% of outstanding shares. The notice states there were no securities sold in the past three months by the reporting person and includes the standard representation that the seller is not aware of any undisclosed material adverse information.
Vital Farms, Inc. filed a Form 144 reporting a proposed sale of 20,000 common shares through J.P. Morgan Securities LLC on Nasdaq with an approximate sale date of 08/13/2025. The filing lists an aggregate market value of $924,200 and shows 44,685,980 shares outstanding.
The securities were acquired on 01/06/2015 in a private transaction from the issuer, with an original acquisition amount of 129,230 shares and payment dated 01/06/2015. The filing reports "Nothing to Report" for securities sold in the past three months. The document includes the standard certification that the filer does not know of any undisclosed material adverse information; certain fields such as the filer relationship to the issuer and the notice date are not specified in the provided text.
FAQ
What is the current stock price of Vital Farms (VITL)?
What is the market cap of Vital Farms (VITL)?
